We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

  • STATUS
    Recruiting
Updated on 10 December 2020
Investigator
Innovaderm Research - University of Michigan
Primary Contact
Innovaderm Research (7.6 mi away) Contact
+24 other location
atopic dermatitis
eczema
dermatitis
adult atopic dermatitis
atopic dermatitis/eczema

Summary

The BLUEPRINT study consists of taking two tablets orally, twice a day, for a period of 4 weeks. This treatment is experimental.

You will have 50% chance to receive BLU-5937 and 50% chance to receive the placebo. There will be a total of 5 visits at the clinic and 2 phone call over a period of 10 weeks. Each on-site visit will last approximately 1.5 to 4 hours except the screening visit that may last up to 3 hours.

Several blood samples will be collected at different occasions such as screening, on day 1, week 2 and week 4. During those visits, a physical evaluation of your eczema and overall health will be done with the study team. 

Description

For more information and to register to the study, please visit the study page: https://innovaderm.com/studies/blueprint-study-atopic-dermatitis/

Details
Condition ATOPIC DERMATITIS, Eczema (Atopic Dermatitis), Dermatitis, Atopic, Eczéma (Dermatite Atopique), Dermatite Atopique
Clinical Study IdentifierTX258787
Last Modified on10 December 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

You are between 18 and 75 years old
Have an itchy eczema
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note